Tag: Solitaire

This advertorial, intended for readers outside the USA only, is sponsored by Medtronic. In light of a recent publication detailing the safe and effective use...

This advertorial is sponsored by Medtronic. Late last year, on 24 November, a decade’s work from a passionate group of physicians bore fruit, with the...

Final results from the PROST randomised controlled trial (RCT) have been published in JAMA Neurology and—according to the study’s leading investigators—provide evidence that thrombectomy...

This advertorial is sponsored by Medtronic. As part of the company’s ongoing commitment to offering physicians access to high-quality clinical data and, subsequently, enabling evidence-based...

This advertorial is sponsored by Medtronic. As the co-founder and chief executive officer of Chestnut Medical, Aaron Berez played a leading role in bringing flow...

This advertorial, sponsored by Medtronic, is intended for readers outside of the USA. Mechanical thrombectomy may be the standard of care for acute ischaemic strokes...

A relatively new introduction to the field of endovascular therapy (EVT) for acute ischaemic stroke, the Skyflow stent retriever (Skyflow), has demonstrated non-inferiority with...

The preliminary results of the SWIFT-DIRECT (Solitaire with the intention for thrombectomy plus IV t-PA versus direct Solitaire stent-retriever thrombectomy in acute anterior circulation...

The Riptide aspiration system is intended for use in the revascularisation of patients with acute ischaemic stroke secondary to intracranial large vessel occlusive disease...

Following an interim analysis of data from the first 182 patients enrolled in DEFUSE 3, the trial has been terminated and is no longer...

The Solitaire™ Platinum Revascularization Device is the next generation into the Solitaire™ family which has an enhanced meaningful visibility that provides feedback during placement,...

The US Food and Drug Administration (FDA) has cleared an expanded indication for the Solitaire stent retriever device (Medtronic). The FDA now allows the...

Stent retriever technology has been named by the Cleveland Clinic as a top medical innovation. It was part of a list of the top...

With the publication of two more stroke trials, the evidence in favour of endovascular treatment in patients with acute ischaemic stroke has reached new heights. Data from SWIFT PRIME and REVASCAT add to that of three other trials-MR CLEAN, EXTEND-IA and ESCAPE-that have begun to change the face of ischaemic stroke treatment.

Two new clinical trials on the treatment of stroke (ESCAPE and EXTEND IA) demonstrate that neurointerventional surgery significantly increases the number of patients who are able to live independently without major neurological disabilities.